Latest Diabetes: Type II news
Oral Orforglipron Noninferior, Superior to Oral Semaglutide for T2DM
posted March 5th
by modernClinician Editorial Team
by modernClinician Editorial Team
Semaglutide May Increase Risk for Nonarteritic Anterior Ischemic Optic Neuropathy
posted February 23rd
by modernClinician Editorial Team
by modernClinician Editorial Team
Maternal Diabetes Linked to Increased Risk for Epilepsy in Offspring
posted February 10th
by modernClinician Editorial Team
by modernClinician Editorial Team
Sodium-Glucose Cotransporter 2 Inhibitors Tied to Lower Use of Gout Medications
posted February 10th
by modernClinician Editorial Team
by modernClinician Editorial Team
Weight-Loss Surgery Produces Lasting Diabetes Remission 
Study IDs Real-World Reasons for Lemborexant Discontinuation 
Treatment Satisfaction Higher for Patients With RA Choosing Their Own Treatment 
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy Related Articles
.jpg)
Pregnancy Complications Linked to Subsequent Risk for Cardiometabolic-Renal Conditions 
GLP-1 Receptor Agonists, SGLT-2is Slow Renal Function Decline in T2D With Albuminuria 
Study IDs Risk Factors for Ketoacidosis in Adults With T2D Receiving SGLT2 Inhibitors 
Genetics, Diabetes Tied to MASLD-Associated Cirrhosis Before Age 50 Monthly Specialist Briefings
Stay Connected
